|Last Price||Today's Change||52-Week Range||Trading Volume|
|428.95||15.91 (+3.85%)||269.50 - 437.64||1.2 million (Above Avg)|
Market data as of 3:59PM 03/05/15. Quotes are delayed by at least 15 min.
NIH-Sponsored Comparative Effectiveness Trial in Diabetic Macular Edema Shows EYLEA® (aflibercept) Injection Demonstrated Significantly Greater Gains in Visual Acuity than Both Bevacizumab and Ranibizumab
02/18/2015 5:00 PM ET